NCT02794441View on ClinicalTrials.gov

Oral Dexamethasone for the Treatment of Acute Migraine Recurrence in the Pediatric Emergency Department

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 28, 2017

Conditions
Migraine
Interventions
DRUG

Dexamethasone

Dexamethasone 0.6mg/kg (maximum 15mg) PO x 1 dose

OTHER

Placebo

Matched oral solution

Trial Locations (1)

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

Children's Hospital of Eastern Ontario

OTHER

NCT02794441 - Oral Dexamethasone for the Treatment of Acute Migraine Recurrence in the Pediatric Emergency Department | Biotech Hunter | Biotech Hunter